Table 1. Correlation between clinicopathological features and DCTPP1 expression in breast cancer tissue.
|
DCTPP1 expression |
Total | χ2 | P-value | ||||
|---|---|---|---|---|---|---|---|
| Variables | ⩽25 N (%) | ⩽50 N (%) | ⩽75 N (%) | ⩽100 N (%) | 161 | ||
| Age | 5.744 | 0.125 | |||||
| ⩽60 | 38 (33.0) | 42 (36.5) | 20 (17.4) | 15 (13.0) | 115 (100.0) | ||
| 60 | 8 (18.2) | 15 (34.1) | 10 (22.7) | 11 (25.0) | 44 (100.0) | ||
| T cassification | 27.151 | 0.001 | |||||
| T1 | 22 (50.0) | 16 (36.4) | 5 (11.4) | 1 (2.3) | 44 (100.0) | ||
| T2 | 14 (17.9) | 29 (37.2) | 20 (25.6) | 15 (19.2) | 78 (100.0) | ||
| T3 | 7 (28.0) | 7 (28.0) | 3 (12.0) | 8 (32.0) | 25 (100.0) | ||
| T4 | 1 (25.0) | 3 (75.0) | 0 (0.0) | 0 (0) | 4 (100) | ||
| N Classification | 7.519 | 0.583 | |||||
| N0 | 19 (24.7) | 29 (37.7) | 18 (23.4) | 11 (14.3) | 77 (100) | ||
| N1 | 12 (36.4) | 11 (33.3) | 4 (12.1) | 6 (18.2) | 33 (100) | ||
| N2 | 11 (34.3) | 14 (43.8) | 3 (9.4) | 4 (12.5) | 32 (100) | ||
| N3 | 4 (25.0) | 4 (25.0) | 4 (25.0) | 4 (25.0) | 16 (100) | ||
| Tumor grade | 15.261 | 0.018 | |||||
| I | 0 (0) | 1 (50.0) | 1 (50.0) | 0 (0) | 2 (100.0) | ||
| II | 30 (38.5) | 26 (33.3) | 12 (15.4) | 10 (12.8) | 78 (100.0) | ||
| III | 4 (9.5) | 15 (35.7) | 14 (33.3) | 9 (21.4) | 42 (100.0) | ||
| Histological type | 15.995 | 0.382 | |||||
| Intraductal | 1 (50.0) | 1 (50.0) | 0 (0) | 0 (0) | 2 (100.0) | ||
| Invasive ductal | 36 (27.3) | 48 (36.4) | 27 (20.5) | 21 (15.9) | 132 (100.0) | ||
| Lobular | 5 (41.7) | 3 (25.0) | 1 (8.3) | 3 (25.0) | 12 (100.0) | ||
| Medullary | 0 (0) | 1 (100) | 0 (0) | 0 (0) | 1 (100.0) | ||
| Mucinous | 4 (40.0) | 5 (50.0) | 1 (10.0) | 0 (0) | 10 (100.0) | ||
| Indeterminate | 0 (0) | 0 (0) | 2 (50) | 2 (50) | 4 (100) | ||
| Clinical stage | 9.094 | 0.168 | |||||
| I | 12 (40.0) | 13 (43.3) | 4 (13.3) | 1 (3.3) | 30 (100.0) | ||
| II | 15 (23.8) | 20 (31.7) | 16 (25.4) | 12 (19.0) | 63 (100.0) | ||
| III | 17 (29.3) | 22 (37.9) | 8 (13.8) | 11 (19.0) | 58 (100.0) | ||
| ER presence | 0.747 | 0.862 | |||||
| Positive | 15 (23.4) | 26 (40.6) | 14 (21.9) | 9 (14.1) | 64 (100) | ||
| Negative | 10 (29.4) | 11 (32.4) | 8 (23.5) | 5 (14.7) | 34 (100) | ||
| PR presence | 4.824 | 0.185 | |||||
| Positive | 15 (25.4) | 27 (45.8) | 11 (18.6) | 6 (10.2) | 59 (100) | ||
| Negative | 10 (26.3) | 10 (26.3) | 10 (26.3) | 8 (21.1) | 38 (100) | ||
| HER-2 presence | 4.23 | 0.234 | |||||
| Positive | 14 (31.1) | 19 (42.2) | 7 (15.6) | 5 (11.1) | 45 (100) | ||
| Negative | 10 (19.2) | 18 (34.6) | 15 (28.8) | 9 (71.3) | 52 (100) | ||
Abbreviations: DCTPP1, dCTP pyrophosphatase 1; N, number.